Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst (Nasdaq: HCAT) will announce its first quarter 2023 operating results on May 9, 2023, after market close. The company will hold a conference call at 5 p.m. E.T. to discuss these results. Interested participants can join via phone at 800-225-9448 for U.S. callers or 203-518-9708 for international callers, citing conference ID HCAT Q123. A live audio webcast will also be available at Health Catalyst's Investor Relations site. The call will be accessible for replay for 90 days post-event. Health Catalyst provides data and analytics technology to healthcare organizations, utilizing a platform powered by over 100 million patient records. Their mission is to enable data-informed healthcare improvements.
Health Catalyst (NASDAQ: HCAT) announced a multi-year partnership with Contexture, the largest health information exchange in the west, on April 4, 2023. This collaboration aims to unify Contexture's technology platforms into a single stack to enhance efficiency and data migration across its network. Contexture's CEO, Melissa Kotrys, emphasized the importance of real-time data access for improving care outcomes. The partnership will leverage Health Catalyst's comprehensive solutions to support performance improvement activities and ensure timely access to data. The move is expected to strengthen healthcare decision-making across participating organizations.
Contexture, the largest health information organization in the western U.S., has announced plans to transition to a unified technology platform for its health information exchange (HIE) services across Arizona and Colorado. The upgrade, set to begin in 2023 and complete by 2025, will enhance data exchange capabilities for approximately 28 million patients. Key benefits include improved electronic health record interoperability, enhanced security, greater flexibility, and a better user experience. This initiative marks an expansion of Contexture's partnership with Health Catalyst, a leader in healthcare data analytics, aimed at improving patient care quality and system efficiency.
Health Catalyst, a leading provider of data analytics technology, has partnered with GI Quality Improvement Consortium (GIQuIC) to enhance the nation's only gastroenterology-focused clinical registry. This collaboration will leverage Health Catalyst's ARMUS solution to streamline data entry and improve reporting for GIQuIC's registry participants. By early 2024, GIQuIC aims to transition its operations for colonoscopy and EGD procedures and expand data collection on various endoscopic procedures and disease states. This partnership is expected to enhance healthcare quality through improved data management and analytics.
Health Catalyst (Nasdaq: HCAT) announced that its CFO, Bryan Hunt, and SVP of Investor Relations, Adam Brown, will participate in the 44th Annual Raymond James Institutional Investors Conference on March 8, 2023, at 8:05 am EST in Orlando. This conference provides a platform for Health Catalyst to discuss its innovative data and analytics solutions aimed at enhancing healthcare decision-making. A replay of the presentation will be available online at Health Catalyst Investor Relations. The company is dedicated to driving measurable improvements in clinical, financial, and operational aspects of healthcare through its extensive analytics capabilities.
Health Catalyst (NASDAQ: HCAT) announced a multi-year contract expansion with INTEGRIS Health, Oklahoma's largest not-for-profit health system, enhancing analytics capabilities across its network. This three-year agreement deepens their partnership, introducing an increased all-access technology subscription and Tech-Enabled Managed Services (TEMS). TEMS aims to reduce labor costs and improve operational efficiencies. The collaboration supports INTEGRIS's commitment to quality and safety outcomes, benefiting patients through data-informed healthcare improvements. Health Catalyst has served over 500 clients leveraging its cloud-based platform, impacting more than 100 million patient records.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
